Skip to main content

Neuropsychological evaluation and rehabilitation in multiple sclerosis (NEuRoMS): protocol for a mixed-methods, multicentre feasibility randomised controlled trial

Topcu, Gogem, Smith, Laura, Mhizha-Murira, Jacqueline, Goulden, Nia, Hoare, Zoë, DRUMMOND, Avril, Fitzsimmons, Deborah, EVANGELOU, Nikos, Schmierer, Klaus, Tallantyre, Emma, and others. (2022) Neuropsychological evaluation and rehabilitation in multiple sclerosis (NEuRoMS): protocol for a mixed-methods, multicentre feasibility randomised controlled trial. Pilot and Feasibility Studies, 8 . Article Number 123. ISSN 2055-5784. (doi:10.1186/s40814-022-01073-5) (KAR id:95430)

PDF Publisher pdf
Language: English


Download this file
(PDF/1MB)
[thumbnail of s40814-022-01073-5.pdf]
Preview
Request a format suitable for use with assistive technology e.g. a screenreader
PDF Author's Accepted Manuscript
Language: English

Restricted to Repository staff only
DOI for this version: 10.1186/s40814-022-01073-5

Contact us about this Publication
[thumbnail of Topcu et al. WP3 protocol paper_AA version.pdf]
Official URL:
https://doi.org/10.1186/s40814-022-01073-5

Abstract

Background: Cognitive problems affect up to 70% of people with multiple sclerosis (MS), which can negatively impact mood, ability to work, and quality of life. Addressing cognitive problems is a top 10 research priority for people with MS. Our ongoing research has systematically developed a cognitive screening and management pathway (NEuRoMS) tailored for people with MS, involving a brief cognitive evaluation and rehabilitation intervention. The present study aims to assess the feasibility of delivering the pathway and will inform the design of a definitive randomised controlled trial (RCT) to investigate the clinical and cost-effectiveness of the intervention and eventually guide its clinical implementation.

Methods: The feasibility study is in three parts. Part 1 involves an observational study of those who receive screening and support for cognitive problems, using routinely collected clinical data. Part 2 is a two-arm, parallel group, multicentre, feasibility RCT with a nested fidelity evaluation. This part will evaluate the feasibility of undertaking a definitive trial comparing the NEuRoMS intervention plus usual care to usual care only, amongst people with MS with mild cognitive problems (n = 60). In part 3, semi-structured interviews will be undertaken with participants from part 2 (n = 25), clinicians (n = 9), and intervention providers (n = 3) involved in delivering the NEuRoMS cognitive screening and management pathway. MS participants will be recruited from outpatient clinics at three UK National Health Service hospitals.

Discussion: Timely screening and effective management of cognitive problems in MS are urgently needed due to the detrimental consequences of cognitive problems on people with MS, the healthcare system, and wider society. The NEuRoMS intervention is based on previous and extant literature and has been co-constructed with relevant stakeholders. If effective, the NEuRoMS pathway will facilitate timely identification and management of cognitive problems in people with MS.

Trial registration: ISRCTN11203922. Prospectively registered on 09.02.2021.

Item Type: Article
DOI/Identification number: 10.1186/s40814-022-01073-5
Subjects: B Philosophy. Psychology. Religion > BF Psychology
R Medicine > RA Public aspects of medicine
R Medicine > RA Public aspects of medicine > RA421 Public health. Hygiene. Preventive Medicine
R Medicine > RA Public aspects of medicine > RA790 Mental health
Divisions: Divisions > Division of Human and Social Sciences > School of Psychology
Depositing User: Laura Smith
Date Deposited: 14 Jun 2022 13:15 UTC
Last Modified: 04 Jul 2023 08:48 UTC
Resource URI: https://kar.kent.ac.uk/id/eprint/95430 (The current URI for this page, for reference purposes)

University of Kent Author Information

  • Depositors only (login required):

Total unique views for this document in KAR since July 2020. For more details click on the image.